|
ATP11B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.082000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.895400E-01 |
| Normal-vs-Stage2 |
7.888100E-02 |
| Normal-vs-Stage3 |
2.617200E-01 |
| Normal-vs-Stage4 |
9.179800E-01 |
| Stage1-vs-Stage2 |
3.163600E-02 |
| Stage1-vs-Stage3 |
8.308500E-02 |
| Stage1-vs-Stage4 |
9.126600E-01 |
| Stage2-vs-Stage3 |
3.846400E-01 |
| Stage2-vs-Stage4 |
7.932200E-02 |
| Stage3-vs-Stage4 |
2.374400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.977600E-01 |
| Normal-vs-AfricanAmerican |
9.647800E-01 |
| Normal-vs-Asian |
6.578000E-01 |
| Caucasian-vs-AfricanAmerican |
7.519200E-01 |
| Caucasian-vs-Asian |
3.756000E-01 |
| AfricanAmerican-vs-Asian |
7.744000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.672800E-01 |
| Normal-vs-Female |
8.050400E-01 |
| Male-vs-Female |
6.092200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.263000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.929400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.861800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.078400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.958900E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.540100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.328600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.420800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.838800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.592400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.380800E-01 |
| Classical-VS-Follicular |
1.83973999999809E-05 |
| Classical-VS-Other |
6.026000E-01 |
| Classical-VS-Normal |
4.599400E-01 |
| Tall-VS-Follicular |
4.489700E-02 |
| Tall-VS-Other |
8.325800E-01 |
| Tall-VS-Normal |
9.806000E-01 |
| Follicular-VS-Other |
3.778200E-01 |
| Follicular-VS-Normal |
1.484130E-02 |
| Other-VS-Normal |
8.143400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.282000E-02 |
| Normal-vs-N1 |
5.781600E-01 |
| N0-vs-N1 |
2.863000E-01 |
|
|
